Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 302, Issue 11, 2012, Pages

  Huynh, Thu P ^a,d   Mah, Vei ^a   Sampson, Valerie B ^d   Chia, David ^a,b   Fishbein, Michael C ^a,b   Horvath, Steve ^a,b   Alavi, Mohammad ^a   Wu, Debbie C ^a   Harper, Jeffrey ^c   Sarafian, Ted ^a   Dubinett, Steven M ^b   Langhans, Sigrid A ^d   Goodglick, Lee ^a,b   Rajasekaran, Ayyappan K ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Disease free survival; Reactive oxygen species; Sodium pump; Tissue microarray

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CIGARETTE SMOKE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REDUCTION;

ADENOCARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; NEOPLASM GRADING; REACTIVE OXYGEN SPECIES; SMOKE; SMOKING; SODIUM-POTASSIUM-EXCHANGING ATPASE; TOBACCO;

EID: 84861878668     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00384.2010     Document Type: Article

References (48)

1. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hyrdoxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593-597, 1989.
2. Aytacogluc BN, Calikoglu M, Tamer L, Coskun B, Sucu N, Kose N, Aktas S, Dikmengil M. Alcohol-induced lung damage and increased oxidative stress. Respiration 73: 100-104, 2006.
3. Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health 11: 1-15, 2008.
4. Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA, Rajasekaran AK. A novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell 16: 1082-1094, 2005.
5. Barwe SP, Kim S, Rajasekaran SA, Bowie JU, Rajasekaran AK. Janus model of the Na, K-ATPase B-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization. J Mol Biol 365: 706-714, 2007.
6. Bhalla DK, Hirata F, Rishi AK, Gairola CG. Cigarette smoke, inflammation, and lung injury: a mechanistic perspective. J Toxicol Environ Health 12: 45-64, 2009.
7. Bonomi PD. Implications of key trials in advanced non-small cell lung cancer. Cancer 116: 1155-1164, 2010.
8. Burns DM, Major JM, Anderson CM, Vaughn JW. Changes in Number of Cigarettes Smoked Per Day: Cross-Sectional and Birth Cohort Analyses Using NHIs, edited by U. S. Department of Health and Human Services PHS. Bethesda, MD: National Institutes of Health, National Cancer Institute, 2003.
9. Chen Z, Krmar RT, Dada L, Efendiev R, Leibiger IB, Pedemonte CH, Katz AI, Sznajder JI, Bertorello AM. Phosphorylation of adaptor protein-2 mu2 is essential for Na, K-ATPase endocytosis in response to either G protein coupled receptor or reactive oxygen species. Am J Respir Cell Mol Biol 35: 127-132, 2006.
10. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985.
11. Dada LA, Welch LC, Zhou G, Ben-Saadon R, Ciechanover A, Sznajder JI. Phosphorylation and ubiquitination are necessary for Na, KATPase endocytosis during hypoxia. Cell Signal 19: 1893-1898, 2007.
12. Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J 35: 202-215, 2010.
13. Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na, K-ATPase by the transcription factor Snail in carcinoma. Mol Biol Cell 15: 1364-1373, 2004.
14. Espineda CE, Seligson DB, Ball WJ, Rao J, Paoltie A, Horvath S, Huang Y, Shi T, Rajasekaran AK. Analysis of the Na, K-ATPase alpha and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 97: 1859-1868, 2003.
15. Faux SR, Tai T, Thorne D, Xu Y, Breheny D, Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14: 90-96, 2009.
16. Gonzalez-Flech B, Evelson P, Ridge K, Sznajder JI. Hydrogen peroxide increases Na, K-ATPase function in alveolar type II cells. Biochim Biophys Acta 1290: 46-52, 1996.
17. Green CR, Rodgman A. The tobacco chemists' research conference: a half century of advances in analytical methodology of tobacco and its products. Rec Adv Tob Sci 22: 131-304, 1996.
18. Gusarova GA, Dada LA, Kelly AM, Brodie B, Witters LA, Chandel NS, Sznajder JI. Alpha1-AMP activated protein kinase regulates hypoxia induced Na, K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol 29: 3455-3464, 2009.
19. Hecht SS, Kassie F, Hatsukami DK. Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers. Nat Rev Cancer 9: 476-488, 2009.
20. Hoshino Y, Mishima M. Redox-based therapeutics for lung diseases. Antiox Redox Signal 10: 701-704, 2008.
21. Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na, K-ATPase B-subunit. Histol Histopathol 23: 459-467, 2008.
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 59: 229-249, 2009.
23. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116, 2001.
24. Khan EM, Lanir R, Danielson AR, Goldkorn T. Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking. FASEB J 22: 910-917, 2008.
25. Kitamura N, Ikekita M, Sato T, Akimoto Y, Hatanaka Y, Kawakami H, Inomata M, Furukawa K. Mouse Na, K-ATPase B1-subunit has a K dependent cell adhesion activity for B-glcNAc-terminating glycans. Proc Natl Acad Sci USA 102: 2796-2801, 2005.
26. Kuper H, Adami HO, Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med 251: 455-466, 2002.
27. Lambrecht N, Corbett Z, Bayle D, Karlish SJD, Sachs G. Identification of the site of inhibition by omeprazole of a α-β fusion protein of the H, K-ATPase using site-directed mutagenesis. J Biol Chem 273: 13179-131728, 1998.
28. Litvan J, Briva A, Wilson MS, Budinger GR, Sznajder JI, Ridge KM. Beta-adrenergic receptor stimulation and adenoviral overexpression of superoxide dismutase prevent the hypoxia-mediated decrease in Na, KATPase and alveolar fluid reabsorption. J Biol Chem 281: 19892-19898, 2006.
29. Liu Z, Muehlbauer KR, Schmeiser HH, Hergenhahn M, Belharazem D, Hollstein MC. p53 mutations in beno(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors. Cancer Res 65: 2583-2587, 2005.
30. Mah V, Seligson DB, Li A, Marquez DC, Wistuba II, Elshimali Y, Fishbein MC, Chia D, Pietra RJ, Goodglick L. Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res 67: 10484-10490, 2007.
31. Mutlu GM, Snyder C, Bellmeyer A, Wang H, Hawkins K, Soberanes S, Welch LC, Ghio AJ, Chandel NS, Kamp D, Sznajder JI, Budinger GR. Airborne particular matter inhibits alveolar fluid reabsorption in mice via oxidant generation. Am J Respir Cell Mol Biol 34: 670-676, 2006.
32. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Br Med J 340: b5569, 2010.
33. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated disorders. Oncogene 21: 2002.
34. Rajasekaran SA, Rajasekaran AK. Na, K-ATPase and epithelial tight junctions. Front Biosci 14: 2130-2148, 2009.
35. Rajasekaran SA, Ball WJ, Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of B-subunit of Na, K-ATPase in human clear-cell renal cell carcinoma. J Urol 162: 574-580, 1999.
36. Rajasekaran SA, Gopal J, Willis D, Espineda C, Twiss JL, Rajasekaran AK. Na, K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells. Mol Biol Cell 15: 3224-3232, 2004.
37. Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, Ahmed MM, Leatherman JM, Mullin JM, Rajasekaran AK. Na, K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther 9: 1515-1524, 2010.
38. Rajasekaran SA, Palmer LG, Quan K, Harper JF, Ball WJ, Bander NH, Peralta Soler A, Rajasekaran AK. Na, K-ATPase B-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Cell Biol 12: 279-295, 2001b.
39. Rajasekaran SA, Palmer LG, Soon SY, Peralta Soler A, Apodaca GL, Harper JF, Zheng Y, Rajasekaran AK. Na, K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell 12: 3717-3732, 2001a.
40. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M, Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262-1266, 2005.
41. Seligson DB, Rajasekaran SA, Yu H, Liu X, Eeva M, Tze S, Ball W Jr, Horvath S, deKernion JB, Rajasekaran AK. Na, K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. J Urol 179: 338-345, 2008.
42. Shoshani L, Contreras RG, Roldan ML, Moreno J, Lazaro A, Balda MS, Matter K, Cereijido M. The polarized expression of Na, K-ATPase in epithelia depends on the association between B-subunits located in neighboring cells. Mol Biol Cell 16: 1071-1081, 2005.
43. Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol 38: 637-646, 2000.
44. Stinchcombe TE, Socinski MA. Current treatments for advanced stage non-small cell lung cancer. Proc Am Thorac Soc 6: 233-241, 2009.
45. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
46. Thorne D, Wilson J, Kumaravel TS, Massey ED, McEwan M. Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutat Res 673: 3-8, 2009.
47. Vagin O, Tokhtaeva E, Sachs G. The Role of B-subunit of the Na, KATPase and its glycosylation in cell-cell adhesion. J Biol Chem 281: 39573-39587, 2006.
48. Wakelee HA, Bernardo P, Johnson DH, Scihller JH. Changes in the natural history of nonsmall cell lung cancer-comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990. Cancer 106: 2208-2217, 2006.